Science Explorer Interactive view Map
Company · Shanghai · China

Viva Biotech (China)

In research, Viva Biotech (China) stands highest in Life Sciences (#3,501 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Molecular Biology — Molecular Biology is 7.4× its share of world research.

vivabiotech.com/en/index.phpROR OpenAlex
World rank, 2022–2025
#7,144
of 28,054 · #15,418 all time
Rank in China
#1,453
of 3,058
Research works
278
▲ 286% vs 2013–17
Citations
4k
14.5 per fractional work
Top-10% rate
22.4%
record average 16.5%
Open access
55%
world 28%

What is Viva Biotech (China) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #3,501 of 7,800 23.0%70 #7366

Each strip is that field’s whole ranked pool, with the notch where Viva Biotech (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Viva Biotech (China) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 7.4× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 35.0 works7.4×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.04× its world share, 8 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.73× its world share, 48 worksBiochemistry, Geneti…Immunology and Microbiology: 5.85× its world share, 9 worksImmunology and Micro…Neuroscience: 1.10× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.55× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.91× its world share, 0 worksChemical EngineeringChemistry: 0.84× its world share, 2 worksChemistryComputer Science: 0.51× its world share, 6 worksComputer ScienceEarth and Planetary Sciences: 0.07× its world share, 0 worksEarth and Planetary …Energy: 0.39× its world share, 1 worksEnergyEngineering: 0.53× its world share, 12 worksEngineeringEnvironmental Science: 0.30× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.74× its world share, 4 worksMaterials SciencePhysics and Astronomy: 0.28× its world share, 1 worksPhysics and AstronomyDentistry: 0.65× its world share, 0 worksDentistryMedicine: 1.83× its world share, 55 worksMedicineNursing: 0.81× its world share, 1 worksNursingVeterinary: 0.61× its world share, 0 worksVeterinaryArts and Humanities: 0.07× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.03× its world share, 0 worksDecision SciencesPsychology: 0.02× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.8×. Every wedge is a field page.

Which keywords describe research at Viva Biotech (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycosylation, Immunotherapy, Monoclonal Antibodies, Therapeutic Antibodies, Cancer, Gene Therapy, Antibody Engineering and Fc Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation12▲ 66×3 topics
  2. Cancer10▲ 4.9×33 topics
  3. Immunotherapy9▲ 8.3×11 topics
  4. Monoclonal Antibodies9▲ 63×3 topics
  5. Inflammation8▲ 2.6×45 topics
  6. Therapeutic Antibodies8▲ 76×2 topics
  7. Epidemiology8▲ 1.27×41 topics
  8. Gene Therapy7▲ 25×4 topics
  9. Antibody Engineering6▲ 76×1 topic
  10. Fc Receptors6▲ 76×1 topic
  11. Tumor Regression6▲ 38×2 topics
  12. Cancer Immunotherapy6▲ 27×3 topics
  13. Oxidative Stress6▲ 2.3×25 topics
  14. Chemotherapy5▲ 4.7×11 topics
  15. Immunity5▲ 7.7×6 topics
  16. Nanoparticles5▲ 2.4×11 topics
  17. Tumor Microenvironment5▲ 6.8×8 topics
  18. Cell Culture4▲ 24×3 topics
  19. Lymphoma4▲ 17×2 topics
  20. Biomarkers4▲ 3.9×12 topics
  21. Monoclonal Antibody4▲ 51×2 topics
  22. CAR T Cells4▲ 34×1 topic
  23. Chimeric Antigen Receptor4▲ 34×1 topic
  24. Innate Immunity4▲ 7.6×9 topics
  25. Targeted Therapy4▲ 10×5 topics
  26. Tumor Targeting4▲ 13×3 topics
  27. Vaccine3▲ 5.3×8 topics
  28. Angiogenesis3▲ 6.3×10 topics
  29. Medicinal Chemistry3▲ 7.5×6 topics
  30. Pharmacokinetics3▲ 7.9×6 topics
  31. Protein3▲ 18×3 topics
  32. Antigen Presentation3▲ 22×2 topics
  33. Biopharmaceuticals3▲ 36×3 topics
  34. Prediction3▲ 25×2 topics
  35. AAV3▲ 45×1 topic
  36. Mammalian Cells3▲ 76×1 topic
  37. Molecular Docking3▲ 14×1 topic
  38. Recombinant Protein3▲ 76×1 topic
  39. Viral Vectors3▲ 45×1 topic
  40. Virtual Screening3▲ 19×1 topic

Which research topics does Viva Biotech (China) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Virus-based gene therapy research and Computational Drug Discovery Methods.

Monoclonal and Polyclona…6Monoclonal and Polyclonal Antibodies Research: 6 fractional worksCAR-T cell therapy research: 4 fractional worksVirus-based gene therapy research: 3 fractional worksComputational Drug Discovery Methods: 3 fractional worksViral Infectious Diseases and Gene Expression in Insects: 3 fractional worksCancer Research and Treatments: 3 fractional worksImmunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksGlycosylation and Glycop…2Glycosylation and Glycoproteins Research: 2 fractional worksProtein Structure and Dy…2Protein Structure and Dynamics: 2 fractional works
Radiology, Nuclear Medicine and ImagingOncologyGeneticsComputational Theory and Mathematics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
  2. 2 CAR-T cell therapy research Oncology 4 works
  3. 3 Virus-based gene therapy research Genetics 3 works
  4. 4 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
  5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 3 works
  6. 6 Cancer Research and Treatments Biotechnology 3 works
  7. 7 Immunotherapy and Immune Responses Immunology 2 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 2 works
  9. 9 Glycosylation and Glycoproteins Research Molecular Biology 2 works
  10. 10 Protein Structure and Dynamics Molecular Biology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.7%not open45.3%

World: 28% of research is openly available.

with international co-authors21.8%domestic only78.2%

World: 19% is written across borders.

How has Viva Biotech (China)'s research output changed?

Output in 2018–2022 was 286% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shanghai

All research institutions in Shanghai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.